Ownership history in CITADEL ADVISORS LLC · 56 quarters on record
This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in SELLAS LIFE SCIENCES GROUP I (SLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 96,700 | -1,796,900 | -94.9% | 0.00% | $365K | $3.77 |
| 2025 Q4 | ADDED | 1,893,600 | +1,360,500 | +255.2% | 0.00% | $7.1M | $3.77 |
| 2025 Q3 | ADDED | 533,100 | +338,743 | +174.3% | 0.00% | $858K | $1.61 |
| 2025 Q3 | ADDED | 194,357 | +128,957 | +197.2% | 0.00% | $313K | $1.61 |
| 2025 Q3 | REDUCED | 65,400 | -19,593 | -23.1% | 0.00% | $105K | $1.61 |
| 2025 Q2 | REDUCED | 84,993 | -374,907 | -81.5% | 0.00% | $186K | $2.19 |
| 2025 Q2 | ADDED | 459,900 | +426,900 | +1293.6% | 0.00% | $1.0M | $2.19 |
| 2025 Q2 | REDUCED | 33,000 | -231,600 | -87.5% | 0.00% | $72K | $2.19 |
| 2025 Q1 | ADDED | 264,600 | +238,300 | +906.1% | 0.00% | $286K | $1.08 |
| 2025 Q1 | REDUCED | 26,300 | -323,205 | -92.5% | 0.00% | $28K | $1.08 |
As of 2025 Q4 — sorted by position size